Division of Hospital Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Division of Clinical Pharmacology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Pharmacotherapy. 2023 Jul;43(7):609-621. doi: 10.1002/phar.2774. Epub 2023 Feb 14.
Early sepsis results in pharmacokinetic (PK) changes due to physiologic alterations. PK changes can lead to suboptimal drug target attainment, risking inadequate coverage from antibiotics like ceftriaxone. Little is known about how ceftriaxone PK and target attainment quantitatively change over time in patients with sepsis or the association between target attainment and outcomes in critically ill children and young adults.
A retrospective analysis of a prospective study was conducted in a single-center pediatric intensive care unit. Septic patients given at least one ceftriaxone dose (commonly as 50 mg/kg every 12 h) and who had blood obtained in both the first 48 h of therapy (early) and afterwards (late) were included. Normalized clearance and central volume were estimated and compared in both sepsis phases. We evaluated target attainment, defined as concentrations above 1× or 4× the minimum inhibitory concentration (MIC) for 100% of dosing intervals, and investigated the association between target attainment and clinical outcomes.
Fifty-five septic patients (median age: 7.5 years) were included. Normalized clearance and central volume were similar in both phases (6.18 ± 1.48 L/h/70 kg early vs. 6.10 ± 1.61 L/h/70 kg late, p = 0.60; 26.6 [IQR 22.3, 31.3] L/70 kg early vs. 24.5 [IQR 22.0, 29.4] L/70 kg late, p = 0.18). Individual percent differences in normalized clearance and central volume between sepsis phases ranged from -39% to 276% and -51% to 212% (reference, late sepsis), respectively. Fewer patients attained the 1× MIC target in late sepsis (82% late vs. 96% early, p = 0.013), which was associated with transition to once daily dosing, typically done due to transfer from the pediatric intensive care unit (PICU) to a lower acuity unit. Failure to attain either target in late sepsis was associated with antibiotic broadening.
Ceftriaxone PK parameters were similar between early and late sepsis, but there were large individual differences. Fewer patients attained MIC targets in late sepsis and all who did not attain the less stringent target received once daily dosing during this period. The failure to attain targets in late sepsis was associated with antibiotic broadening and could be an area for antibiotic stewardship intervention.
早期败血症会导致药代动力学(PK)变化,这是由于生理变化引起的。PK 变化可能导致药物目标达不到最佳状态,从而使头孢曲松等抗生素的覆盖范围不足。目前还不太清楚败血症患者的头孢曲松 PK 和目标实现如何随时间发生定量变化,也不清楚目标实现与危重症儿童和青少年的结局之间的关系。
对单中心儿科重症监护病房进行的前瞻性研究进行了回顾性分析。纳入了至少接受一次头孢曲松治疗(通常为 50mg/kg,每 12 小时一次)且在治疗的前 48 小时(早期)和之后(晚期)获得血液样本的败血症患者。在两个败血症阶段估计并比较了标准化清除率和中心容积。我们评估了目标达标情况,定义为浓度在 100%的给药间隔内超过最低抑菌浓度(MIC)的 1 倍或 4 倍,并且调查了目标达标情况与临床结局之间的关系。
共纳入 55 例败血症患者(中位年龄:7.5 岁)。早期和晚期的标准化清除率和中心容积相似(早期 6.18±1.48L/h/70kg 与晚期 6.10±1.61L/h/70kg,p=0.60;早期 26.6[IQR 22.3,31.3]L/70kg 与晚期 24.5[IQR 22.0,29.4]L/70kg,p=0.18)。败血症阶段之间标准化清除率和中心容积的个体百分比差异范围分别为-39%至 276%和-51%至 212%(参考值为晚期败血症)。晚期败血症中达到 1×MIC 目标的患者较少(82%晚期 vs. 96%早期,p=0.013),这与从儿科重症监护病房(PICU)转至低危病房后转为每日一次给药有关。晚期败血症中未能达到任一目标均与抗生素扩大治疗有关。
头孢曲松 PK 参数在早期和晚期败血症之间相似,但个体差异较大。晚期败血症中达到 MIC 目标的患者较少,所有未达到较宽松目标的患者在此期间接受每日一次给药。晚期败血症中未能达到目标与抗生素扩大治疗有关,可能是抗生素管理干预的一个领域。